Business · 13/03/2019Updated: 10/17/2026 · 1 min read
FDA Releases Guidance on Including Adolescent Patients in Adult Oncology Clinical Trials
Summary
The FDA has released a final guidance for industry to help pharmaceutical companies, clinical investigators, and review boards include adolescent patients (ages 12-17) in adult oncology clinical trials, addressing patient selection, dosing, safety, and ethics.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →